 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$1.91 |
$1.96 |
$1.81 |
$1.85 |
37.90K | | 04/19/2024 |
$1.89 |
$1.95 |
$1.77 |
$1.78 |
10.30K | | 04/22/2024 |
$1.80 |
$1.93 |
$1.73 |
$1.75 |
25.50K | | 04/23/2024 |
$1.71 |
$1.85 |
$1.68 |
$1.79 |
28.40K | | 04/24/2024 |
$1.86 |
$2.35 |
$1.85 |
$2.30 |
439.40K |
|
|
| Cyclacel Pharmaceuticals is a biopharmaceutical company engaged in developing cancer medicines based on cell cycle, transcriptional regulation and mitosis control biology. The transcriptional regulation program is evaluating fadraciclib, a Cyclin Dependent Kinase 2/9 (CDK2/9) inhibitor, in solid tumors and hematological malignancies. CDKs also provide pivotal functions in the regulation of transcription, DNA repair and metastatic spread. The anti-mitotic program is evaluating plogosertib, a polo-like kinase, or PLK inhibitor, in solid tumors and hematological malignancies. PLK1 is a serine/threonine kinase with a central role in cell division, or the mitotic phase of the cell cycle. | |
|
Cyclacel Pharmaceuticals (CYCC) has the following price history information. Looking back at CYCC historical stock prices for the last five trading days, on April 18, 2024, CYCC opened at $1.91, traded as high as $1.96 and as low as $1.81, and closed at $1.85. Trading volume was a total of 37.90K shares. On April 19, 2024, CYCC opened at $1.89, traded as high as $1.95 and as low as $1.77, and closed at $1.78. Trading volume was a total of 10.30K shares. On April 22, 2024, CYCC opened at $1.80, traded as high as $1.93 and as low as $1.73, and closed at $1.75. Trading volume was a total of 25.50K shares. On April 23, 2024, CYCC opened at $1.71, traded as high as $1.85 and as low as $1.68, and closed at $1.79. Trading volume was a total of 28.40K shares. On April 24, 2024, CYCC opened at $1.86, traded as high as $2.35 and as low as $1.85, and closed at $2.30. Trading volume was a total of 439.40K shares.
CYCC Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cyclacel Pharmaceuticals shares, starting with a $10,000 purchase of CYCC, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$12,060.00 |
|
| End price/share: |
$2.30 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.98% |
|
| Average Annual Total Return: |
-57.54% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1.91 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $1.85 | | 04/19/2024 | $1.78 | | 04/22/2024 | $1.75 | | 04/23/2024 | $1.79 | | 04/24/2024 | $2.30 |
|
|
Free CYCC Email Alerts:
